| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.33 | 3e-11 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.29 | 1e-08 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.14 | 0.009 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.099 | 0.07 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.083 | 0.1 |